Index
Admin Log in

Search form

Home
Organizations

Cardiovascular Diabetology, Journal

Overview

publication venue for

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™). 2014

Campus Advisories
Copyright
Privacy Policy
Terms of Use
Contact GW
A - Z Index

GW is committed to digital accessibility. If you experience a barrier that affects your ability to access content on this page, let us know via the Accessibility Feedback Form.